FMCG Gurus – GLP-1 – Diet Food Killer or Market Opportunity – Trend Report 2025
Report Description:
This report explores the growing influence of GLP-1 medications on food and drink consumption, assessing whether these drugs will disrupt established dietary habits or open new opportunities for product innovation. As usage increases, consumers are reassessing their health routines and purchasing choices, with reduced appetite, evolving nutritional needs, side-effect management, and interest in natural alternatives reshaping expectations of food and drink brands.
The report investigates how GLP-1 adoption is shifting eating behaviours and driving demand for nutrient-dense, functional products that support weight management in a responsible way. As people balance the advantages and limitations of GLP-1 treatments, they are showing greater openness to solutions such as high-protein foods, satiety-boosting formulations, and products designed to naturally stimulate GLP-1 hormones. Together, these changes create both challenges and opportunities for the industry to innovate, communicate clearly, and align with new health priorities.
This report will look at the following areas:
- How GLP-1 medication usage is reshaping consumer eating habits.
- Consumer attitudes toward GLP-1 medication.
- Demand for alternatives positioned to naturally stimulate GLP-1 hormones.
- The emergence of new consumer segments such as committed users, casual users, and short-term users.
- Opportunities for food and drink brands within a GLP-1-influenced market.
FMCG Gurus – GLP-1 – Diet Food Killer or Market Opportunity – Trend Report 2025
Report Description:
This report explores the growing influence of GLP-1 medications on food and drink consumption, assessing whether these drugs will disrupt established dietary habits or open new opportunities for product innovation. As usage increases, consumers are reassessing their health routines and purchasing choices, with reduced appetite, evolving nutritional needs, side-effect management, and interest in natural alternatives reshaping expectations of food and drink brands.
The report investigates how GLP-1 adoption is shifting eating behaviours and driving demand for nutrient-dense, functional products that support weight management in a responsible way. As people balance the advantages and limitations of GLP-1 treatments, they are showing greater openness to solutions such as high-protein foods, satiety-boosting formulations, and products designed to naturally stimulate GLP-1 hormones. Together, these changes create both challenges and opportunities for the industry to innovate, communicate clearly, and align with new health priorities.
This report will look at the following areas:
- How GLP-1 medication usage is reshaping consumer eating habits.
- Consumer attitudes toward GLP-1 medication.
- Demand for alternatives positioned to naturally stimulate GLP-1 hormones.
- The emergence of new consumer segments such as committed users, casual users, and short-term users.
- Opportunities for food and drink brands within a GLP-1-influenced market.
How This Report Can Benefit the Industry:
- Identifies the scale and nature of GLP-1’s disruption across the FMCG industry.
- Helps brands understand how reduced appetite, lifestyle changes, and new priorities shape product demand, helping guide innovation.
Files included in this report:
FMCG-Gurus-GLP-1-Diet-Food-Killer-or-Market-Opportunity-Trend-Report-2025.pdf
FMCG-Gurus-GLP-1-Diet-Food-Killer-or-Market-Opportunity-Trend-Report-2025.pptx